产品名称
N -去甲基氯氮平,
form
powder
Quality Level
drug control
regulated under CDSA - not available from Sigma-Aldrich Canada
SMILES string
Clc1ccc2Nc3ccccc3C(=Nc2c1)N4CCNCC4
InChI
1S/C17H17ClN4/c18-12-5-6-15-16(11-12)21-17(22-9-7-19-8-10-22)13-3-1-2-4-14(13)20-15/h1-6,11,19-20H,7-10H2
InChI key
JNNOSTQEZICQQP-UHFFFAOYSA-N
Gene Information
human ... KCNH1(3756)
Application
本文以 N-去甲基氯氮平为标准,对中国难治性精神分裂症患者的氯氮平血药浓度进行了定量测定。
Biochem/physiol Actions
N-去甲基氯氮平是毒蕈碱型乙酰胆碱受体的激动剂,已知具有抗精神病作用。它通过拮抗突触内 GABA(γ-氨基丁酸)受体阻止突触传递。
氯氮平的主要代谢产物;有效的 5-HT 2 5-羟色胺受体拮抗剂和克隆的 5-HT 6 和 5-HT 7 5-羟色胺受体的配体。也是 M 1 毒蕈碱受体的变构增效剂。
signalword
Warning
Hazard Classifications
Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
Atypical Antipsychotics-Advances in Research and Application (2012)
Plasma clozapine levels and clinical response in treatment-refractory Chinese schizophrenic patients
Wong JO, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry, 30(2), 251-264 (2006)
Frontiers in Clinical Drug Research- Central Nervous System, 19-19 (2013)
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| D5676-10MG | 04061833586631 |
| D5676-5MG | 04061832090511 |
